HPV testing in cervical cytology practice: It's all about choice

Acta Cytologica

Volumn 49, Issue 2, 2005, Pages 117-119

  Stoler, Mark H ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Cervical cancer; Human papillomavirus; Mass screening

Indexed keywords

BIOPSY; CALCULATION; COLPOSCOPY; COST EFFECTIVENESS ANALYSIS; EDITORIAL; EMERGENCY HEALTH SERVICE; FOLLOW UP; FOOD AND DRUG ADMINISTRATION; HUMAN; HUMAN PAPILLOMAVIRUS TESTING; LABORATORY; LABORATORY DIAGNOSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; SAFETY; SCREENING; SENSITIVITY AND SPECIFICITY; STATISTICS; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; WART VIRUS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES;

EID: 15244359679     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000326117     Document Type: Editorial

References (11)

1. Cuzick J, Szarewski A, Cubie H, et al: Management of women who test positive for high-risk types of human papillomavirus: The HART study. Lancet 2003;362:1871-1876
2. ALTS Group: A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol 2003;188:1393-1400
3. ALTS Group: Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 2003;188:1383-1392
4. Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh-Ngai J, Kurman RJ, Ransley JE, Fetterman BJ, Hartinger JS, Mcintosh KM, Pawlick GF, Hiatt RA: Identifying women with cervical neoplasia: Using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA 1999;281:1605-1610
5. Bewtra C, Xie Q, Soundararajan S, Gatalica Z, Hatcher L: Genital human papillomavirus testing by in situ hybridization in liquid-based, atypical cytologic materials and follow-up biopsies. Acta Cytol 2005;49:127-131
6. Qureshi MN, Rudelli RD, Tubbs RR, Biscotti CV, Layfield LJ: Role of HPV DNA testing in predicting cervical intraepithelial lesions: Comparison of HC HPV and ISH HPV Diagn Cytopathol 2003;29:149-155
7. Wright TC Jr, Schiffman M, Solomon D, Cox JT, Garcia F, Goldi S, Hatch K, Noller KL, Roach N, Runowicz C, Saslow D: Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet Gynecol 2004;103:304-309
8. Wright TC Jr, Cox JT, Massad LS, Carlson J, Twiggs LB, Wilkinson EJ: 2001 Consensus guidelines for the management of women with cervical intraepithelial neoplasia. Am J Obstet Gynecol 2003;189:295-304
9. Stoler MH: Testing for human papillomavirus: Data driven implications for cervical neoplasia management. Clin Lab Med 2003;23:569-583
10. Wright TC Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ: 2001 Consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 2002;287:2120-2129
11. Stoler MH: New Bethesda terminology and evidence-based management guidelines for cervical cytology findings. JAMA 2002;287:2140-2141